Article Details

Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics - FinSMEs

Retrieved on: 2022-10-04 20:40:42

Tags for this article:

Click the tags to see associated articles and topics

Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics - FinSMEs. View article details on hiswai:

Excerpt

Alexion, AstraZeneca Rare Disease acquired LogicBio Therapeutics (NASDAQ: LOGC), a Lexington, MA-based clinical-stage genomic medicine company.

Article found on: www.finsmes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up